David C. Hanley
CIK: 0001865826
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nuvation Bio Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 27, 2026NUVB
Nuvation Bio Inc.
Award(A)DirectStock Option (Right to Buy)
748.1K shares- - Nov 19, 2025NUVB
Nuvation Bio Inc.
Exercise(M)Direct200K shares at avg. $1.87$374K - Nov 19, 2025NUVB
Nuvation Bio Inc.
Sale(S)Direct200K shares at avg. $7.14$1.4M - Feb 28, 2025NUVB
Nuvation Bio Inc.
Award(A)DirectStock Option (Right to Buy)
500K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | Award(A) Stock Option (Right to Buy) | 748,130 | - | - | Direct |
| Nov 19, 2025 | NUVB Nuvation Bio Inc. | Exercise(M) | 200,000 | $1.87 | $374,000 | Direct |
| Nov 19, 2025 | NUVB Nuvation Bio Inc. | Sale(S) | 200,000 | $7.14 | $1,427,680 | Direct |
| Feb 28, 2025 | NUVB Nuvation Bio Inc. | Award(A) Stock Option (Right to Buy) | 500,000 | - | - | Direct |
1-4 of 4 transactions
About Hanley David C.
Hanley David C. (SEC CIK 0001865826) files insider reports with the SEC as CHIEF TECHNICAL OPERATIONS of Nuvation Bio Inc. (NUVB).
Signal8 holds 3 ownership filings by Hanley David C., all Form 4s, filed between Mar 4, 2025 and Mar 3, 2026. Those filings report 4 transactions, from Feb 28, 2025 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hanley David C.'s filings is in NEW YORK, NY.
Recent filings by Hanley David C.
Other insiders filing for Nuvation Bio Inc. (NUVB)
- Hattersley Gary, CHIEF SCIENTIFIC OFFICER
- Sauvage Philippe, Chief Financial Officer
- Markel Stacy, CHIEF PEOPLE OFFICER
- Wentworth Kerry, CHIEF REGULATORY OFFICER
- Mashal Robert, Director
- VERNON W ANTHONY, Director